Please login to the form below
NHS
This page shows the latest NHS news and features for those working in and with pharma, biotech and healthcare.
ABPI welcomes new NHS research guidance for integrated care systems
A research-active NHS delivers huge value to patients, staff and the system itself. ... Around 25% of the world’s top 100 prescription medicines are discovered and developed in the UK, according to NHS England.
Latest news
-
ABPI sets out proposals for UK government to support the NHS and economy
The Association of the British Pharmaceutical Industry (ABPI) has published a new set of proposals for the UK government aimed at supporting both the NHS and economy. ... The current VPAG, introduced in 2019, caps the growth of NHS branded medicine
-
UK government commissions independent review into clinical trials
NHS patient access to innovative medicines all across the UK,” adding that the UK has traditionally been a “strong global location for trials”. ... is critical if we are to deliver the UK’s ambitions for the life sciences sector and to support
-
NICE publishes final draft guidance recommending three COVID-19 treatments
the NHS can continue to deliver maximum value to the taxpayer.”.
-
ICR discovery could lead to new series of cancer drugs
In November 2022, researchers from the ICR and the Royal Marsden NHS Foundation Trust revealed joint plans to create a new generation of treatments that target the ecosystems within the body
-
Sanofi’s enzyme replacement therapy available on NHS to Pompe disease patients
Sanofi has announced that its long-term enzyme replacement therapy will now be available on the NHS to patients with Pompe disease, following a recommendation from the National Institute for Health
More from news
Approximately 427 fully matching, plus 1,895 partially matching documents found.
Latest Intelligence
-
Digital technology: a significant change in healthcare innovation
For example, the National Health Service (NHS) in the UK is updating a mobile application that improves access to healthcare services nationally.
-
Unlocking the potential of data sharing
This resulted in an 80% reduction of heart failure hospitalisations within just five months of monitoring, which is not only beneficial for patients, but also for the NHS, with each complex
-
Why pharma needs to ‘walk the talk’ on improving the greener patient journey
In the recent NHS paper on Delivering a ‘Net Zero’ National Health Service, one of the main challenges for the pharmaceutical industry is how to reduce emissions from medicines, which currently
-
Pharma’s vital role in sustainability and corporate social responsibility
NHS in England has given its supply chain five years to fall in line with its plans to hit carbon net zero by 2045.
-
Concerns about data security are building a strong case for clinical mobility in EMEA
For example, the UK’s NHS and the EU’s European Medicines Agency both have updated guidance on BYOD for healthcare staff and for clinical trials.
More from intelligence
Approximately 34 fully matching, plus 215 partially matching documents found.
Latest appointments
-
Hanover Health appoints James Mole as a director
Mole joins the agency from his previous role as deputy director of communications at NHS England and will report to leads Alex Davies and Emma Gorton. ... He also worked closely with leading medics, including NHS national medical director Professor Sir
-
Hanover appoints Ian Dodge to its senior adviser panel
Dodge was the former national director of strategy, primary care and community services for NHS England. ... Hanover Health – part of the Hanover Group – has announced that it has appointed former NHS England national director of strategy, primary
-
NHS England appoints Chris Hopson as its new chief strategy officer
With over 225 members, NHS Providers is the membership organisation for the NHS acute hospitals and community, mental health and ambulance services. ... Chris has led NHS Providers with rigour and determination over the last ten years and has been a
-
Amanda Pritchard becomes NHS England’s first female chief executive
She first joined the NHS as a graduate management trainee in 1997 after graduating from Oxford University. ... She has held a variety of additional NHS management positions over the course of her career.
-
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life Sciences
First launched in 2012, the 100, 000 Genome Project had ambitious plans to map the genomes of NHS patients to deliver treatments for those with rare inherited diseases and cancer. ... of Health and Social Care, Office for Life Sciences, London Borough of
More from appointments
Approximately 18 fully matching, plus 98 partially matching documents found.
Latest from PMHub
-
WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
One report by the NHS Confederation highlights the key barriers to PSP uptake, noting lack of awareness of PSPs for both patients and healthcare professionals (HCPs see below) as a key
-
Could femtech be the answer to the gender health gap?
18. The product was such a success that it is now offered to affected women via the NHS. ... Published September 10, 2018. Accessed November 4, 2021. Wilkinson E. NICE: More evidence needed before NHS can adopt use of contraception app.
-
Femtech: Transforming the future of women's healthcare
to access care in a more convenient, personalised and consumer-centric manner.As a key goal set out in the NHS Long Term Plan, the concept of personalised care isn’t ... However, for women to truly benefit, the NHS and the Femtech industry must work as
-
VPAS: The importance of making the right arguments, even in challenging times
Deterring investment in the UK will mean new treatments get into NHS referral pathways later, or not at all. ... sciences sector to deliver new medical innovations to NHS patients and the wider public.
-
Putting prevention at the heart of the future of the NHS
Prioritising the prevention of cardiovascular disease (CVD) should be at the heart of plans to safeguard the long-term sustainability of the NHS. ... This is money that could make a significant difference to an NHS creaking under its current burden.
More from PMHub
Approximately 63 fully matching, plus 273 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- 2023 PM Society Awards – winners announced
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- FDA external report recommends actions to address US opioid crisis
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Inizio appoints Stefanie Christmas as global head of DE&I
- Rare diseases: not so rare after all
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis
- Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
- Havas Health & You appoints Alex Okada as chief creative officer of Havas Lynx Group
PMHub
Mednet Group
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
